1. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369(9578):2031–41.
2. Logroscino G, Traynor BJ, Hardiman O, Chiò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81(4):385–90.
3. Xu L, Chen L, Wang S, Feng J, Liu L, Liu G, et al. Incidence and prevalence of amyotrophic lateral sclerosis in urban China: a national population-based study. J Neurol Neurosurg Psychiatry. 2020;91(5):520–5.
4. Marin B, Hamidou B, Couratier P, Nicol M, Delzor A, Raymondeau M, et al. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe: the French register of ALS in Limousin (FRALim register). Eur J Neurol. 2014;21(10):1292–9; e78–9.
5. Dandaba M, Couratier P, Labrunie A, Nicol M, Hamidou B, Raymondeau M, et al. Characteristics and prognosis of oldest old subjects with amyotrophic lateral sclerosis. Neuroepidemiology. 2017;49(1–2):64–73.